Atezo-Brain: Single Arm Phase II Study of Atezolizumab Plus Chemotherapy in Stage IV NSCLC With Untreated Brain Metastases
Por:
Nadal, E, Massuti, B, Huidobro, G, Castro, RL, Estival, A, Mosquera, J, Sullivan, I, Felip, E, Blasco, A, Guirado, M, Simo, M, Pereira, E, Navarro, V and Bruna, J
Publicada:
1 oct 2021
Resumen:
Filiaciones:
Nadal, E:
Catalan Inst Oncol LHospitalet, Barcelona, Spain
Massuti, B:
Hosp Gen Univ, Alicante, Spain
Huidobro, G:
Hosp Alvaro Cunqueiro, Vigo, Spain
Castro, RL:
Hosp Clin Univ Valladolid, Valladolid, Spain
:
Hosp Badalona Germans Trias & Pujol, B Argo, Inst Catala Oncol Badalona, Barcelona, Spain
Mosquera, J:
Hosp Univ A Coruna, La Coruna, Spain
Sullivan, I:
Hosp Santa Creu & Sant Pau, Barcelona, Spain
:
Vall dHebron Univ Hosp, Barcelona, Spain
Inst Oncol, Barcelona, Spain
Blasco, A:
Hosp Gen Univ Valencia, Valencia, Spain
Guirado, M:
Hosp Gerenal Univ Elche, Elche, Spain
Simo, M:
Catalan Inst Oncol LHospitalet, Barcelona, Spain
Pereira, E:
Spanish Lung Canc Grp, Barcelona, Spain
Navarro, V:
Catalan Inst Oncol LHospitalet, Barcelona, Spain
Bruna, J:
Catalan Inst Oncol LHospitalet, Barcelona, Spain
|